{"id":"https://openalex.org/W2887403283","doi":"https://doi.org/10.1158/1538-7445.am2018-lb-288","title":"Abstract LB-288: A highly selective small molecule CSF-1R inhibitor demonstrates strong immunomodulatory activity in syngeneic models","display_name":"Abstract LB-288: A highly selective small molecule CSF-1R inhibitor demonstrates strong immunomodulatory activity in syngeneic models","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2887403283","doi":"https://doi.org/10.1158/1538-7445.am2018-lb-288","mag":"2887403283"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-lb-288","doi":"https://doi.org/10.1158/1538-7445.am2018-lb-288","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-lb-288","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006105091","display_name":"Shuqun Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuqun Yang","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103176549","display_name":"Baowei Zhao","orcid":"https://orcid.org/0000-0003-4224-6191","observed_orcids":["https://orcid.org/0000-0003-4224-6191","https://orcid.org/0009-0009-7799-8167"]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Baowei Zhao","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mingming Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mingming Zhang","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042816586","display_name":"Yuan Zhao","orcid":"https://orcid.org/0000-0002-7512-7116","observed_orcids":["https://orcid.org/0000-0002-7512-7116"]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuan Zhao","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100721796","display_name":"Xin Chen","orcid":"https://orcid.org/0000-0002-2628-4027","observed_orcids":["https://orcid.org/0000-0002-2628-4027","https://orcid.org/0009-0002-8669-0016","https://orcid.org/0009-0007-7563-8673"]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Chen","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100433830","display_name":"Lei Justan Zhang","orcid":"https://orcid.org/0000-0001-7409-6090","observed_orcids":["https://orcid.org/0000-0001-7409-6090"]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lei Zhang","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112489672","display_name":"Hongping Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongping Yu","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057951270","display_name":"Zhui Chen","orcid":"https://orcid.org/0009-0005-8600-3601","observed_orcids":["https://orcid.org/0009-0005-8600-3601"]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhui Chen","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113872866","display_name":"Y.\u2010C. XU","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266986","display_name":"Abbisko Therapeutics Co., Ltd. (China)","ror":"https://ror.org/00naw5y04","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405266986"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yaochang Xu","raw_affiliation_strings":["Abbisko Therapeutics, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbisko Therapeutics, Shanghai, China","institution_ids":["https://openalex.org/I4405266986"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405266986"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"LB","last_page":"288"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/csf1r-inhibitor","display_name":"CSF1R inhibitor","score":0.9599999785423279},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.722000002861023},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8289999961853027},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9919999837875366},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7630000114440918},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9229999780654907},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.8820000290870667},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.40799999237060547},{"id":"https://openalex.org/keywords/macrophage-repolarization","display_name":"macrophage repolarization","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5426206588745117},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5167457461357117},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4914058446884155},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.48302993178367615},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.47358256578445435},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.45243504643440247},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4503730833530426},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4417877793312073},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.43111446499824524},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4118781089782715},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4052988588809967},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3451375961303711},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.303016722202301},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26867207884788513},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24590447545051575},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23343166708946228},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.218550443649292},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13370999693870544}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-lb-288","doi":"https://doi.org/10.1158/1538-7445.am2018-lb-288","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-lb-288","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282973410","https://openalex.org/W2885250652","https://openalex.org/W4296619108","https://openalex.org/W4251060961","https://openalex.org/W4308346200","https://openalex.org/W4396516884","https://openalex.org/W2810907364","https://openalex.org/W1987681569","https://openalex.org/W4245427071","https://openalex.org/W7165472995"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"CSF-1R":[2,21,36,85,104,185,193,323,357],"is":[3,23,314],"the":[4,14,39,59,196,216,370],"receptor":[5,114,231],"for":[6,25,58,100,373],"Colony-Stimulating":[7],"Factor":[8],"1":[9],"(CSF-1),":[10],"which":[11,213],"belongs":[12],"to":[13,38],"type":[15],"III":[16],"protein":[17],"tyrosine":[18,115,218,232],"kinase":[19,219],"family.":[20],"signaling":[22],"critical":[24],"macrophage/myeloid-derived":[26],"suppressing":[27],"cells":[28],"(MDSC)":[29],"recruitment,":[30],"proliferation,":[31,122],"and":[32,41,45,70,81,96,107,123,151,181,195,241,251,272,296,319],"survival.":[33],"Inhibition":[34],"of":[35,43,61,130,137,192,198,245,262,269,369],"leads":[37],"reduction":[40],"repolarization":[42],"macrophages":[44],"MDSCs":[46],"in":[47,92,134,147,157,189,215,247,265,301,363],"tumor":[48],"microenvironment,":[49],"offering":[50],"potential":[51],"combinatory":[52],"synergy":[53],"with":[54,221],"immune-oncology":[55],"checkpoint":[56],"antibodies":[57],"treatment":[60],"multiple":[62],"cancers.":[63],"By":[64],"using":[65],"state-of-art":[66],"computational":[67],"structure":[68],"analysis":[69,154],"medicinal":[71],"chemistry":[72],"design,":[73],"we":[74],"have":[75],"discovered":[76],"a":[77,315],"novel,":[78],"highly":[79,316,353],"selective,":[80,318],"potent":[82,179],"small":[83,321,355],"molecule":[84,322,356],"inhibitor,":[86],"ABSK-021.":[87],"Method:":[88],"ABSK-021":[89,131,177,206,246,257,275,287],"was":[90,117,132,155,168,277],"evaluated":[91],"biochemical":[93,180],"ADP-Glo":[94],"assay":[95,99],"Cell-Titer":[97],"Glo":[98],"its":[101,226],"inhibition":[102,191,290],"on":[103,291],"enzymatic":[105],"activity":[106,362],"cellular":[108,121,182],"proliferation.":[109],"Its":[110,164,325],"selectivity":[111,210,228],"against":[112,184,211,229],"other":[113,230,297],"kinases":[116],"analyzed":[118],"by":[119,171,279,311],"ELISA,":[120],"KinomeScan":[124,223],"assays.":[125,175],"The":[126],"pharmacokinetics":[127],"(PK)":[128],"profile":[129,167,244,327],"characterized":[133],"four":[135],"species":[136],"animals":[138],"(mouse,":[139],"rat,":[140,249],"dog,":[141,250],"monkey).":[142],"Efficacy":[143,253],"studies":[144,254,284],"were":[145],"conducted":[146],"two":[148],"syngeneic":[149,266,364],"models,":[150],"flow":[152,280],"cytometry":[153,281],"performed":[156],"tumor-bearing":[158],"mice":[159],"after":[160,274],"short":[161],"term":[162],"dosing.":[163],"preliminary":[165],"toxicity":[166],"also":[169,224],"generated":[170],"several":[172],"classical":[173],"safety":[174,299],"Results:":[176],"has":[178,207,288],"activities":[183],"(IC50<30":[186],"nM),":[187],"resulting":[188],"strong":[190,360],"phosphorylation":[194],"proliferation":[197],"bone-marrow":[199],"derived":[200],"macrophage":[201,271],"at":[202],"low":[203],"nM":[204],"concentration.":[205],"over":[208],"40-fold":[209],"KIT/FLT3/PDGFR-alpha/VEGFR2,":[212],"are":[214],"same":[217],"family":[220,293],"CSF-1R.":[222],"revealed":[225],"excellent":[227],"kinases.":[233],"In":[234],"vivo":[235],"PK":[236],"study":[237],"demonstrated":[238],"high":[239],"exposure":[240],"superior":[242,326],"DMPK":[243],"mouse,":[248],"monkey.":[252],"showed":[255,285],"that":[256,286],"strongly":[258],"enhanced":[259],"anti-tumor":[260],"efficacy":[261],"anti-PD-1":[263],"antibody":[264],"models.":[267],"Reduction":[268],"tumor-associated":[270],"MDSC":[273],"dosing":[276],"confirmed":[278],"analysis.":[282],"Safety":[283],"no":[289],"CYP":[292],"members,":[294],"hERG,":[295],"43":[298],"targets":[300],"CEREP's":[302],"SafetyScreen":[303],"panel":[304],"(IC50>10":[305],"\u03bcM).":[306],"Conclusion:":[307],"ABSK-021,":[308],"presented":[309],"here":[310],"Abbisko":[312],"Therapeutics,":[313],"potent,":[317],"oral-available":[320],"inhibitor.":[324],"supports":[328],"fast-track":[329],"preclinical":[330],"development.":[331],"Citation":[332],"Format:":[333],"Shuqun":[334],"Yang,":[335],"Baowei":[336],"Zhao,":[337,341],"Mingming":[338],"Zhang,":[339,345],"Yuan":[340],"Xin":[342],"Chen,":[343,349],"Lei":[344],"Hongping":[346],"Yu,":[347],"Zhui":[348],"Yaochang":[350],"Xu.":[351],"A":[352],"selective":[354],"inhibitor":[358],"demonstrates":[359],"immunomodulatory":[361],"models":[365],"[abstract].":[366],"In:":[367],"Proceedings":[368],"American":[371],"Association":[372],"Cancer":[374,387],"Research":[375],"Annual":[376],"Meeting":[377],"2018;":[378],"2018":[379],"Apr":[380],"14-18;":[381],"Chicago,":[382],"IL.":[383],"Philadelphia":[384],"(PA):":[385],"AACR;":[386],"Res":[388],"2018;78(13":[389],"Suppl):Abstract":[390],"nr":[391],"LB-288.":[392]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2018-08-22T00:00:00"}